Recent News

• 11.10.2025 - Codexis Announces Signing of Lease for GMP Manufacturing Facility
• 11.06.2025 - Codexis Reports Third Quarter 2025 Financial Results
• 11.06.2025 - Codexis Reports Third Quarter 2025 Financial Results
• 10.29.2025 - Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
• 10.23.2025 - Codexis to Report Third Quarter 2025 Financial Results on November 6
• 10.23.2025 - Codexis to Report Third Quarter 2025 Financial Results on November 6
• 08.28.2025 - Codexis to Participate in Cantor Global Healthcare Conference
• 08.28.2025 - Codexis to Participate in Cantor Global Healthcare Conference
• 08.13.2025 - Codexis Reports Second Quarter 2025 Financial Results
• 08.13.2025 - Codexis Reports Second Quarter 2025 Financial Results

Recent Filings

• 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.06.2025 - 8-K Current report
• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.14.2025 - 144 Report of proposed sale of securities
• 10.14.2025 - 144 Report of proposed sale of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors